22 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
25086681	57	Structure-based optimization of non-peptidic Cathepsin D inhibitors.	Merck
8120867	70	Non-peptide renin inhibitors containing 2-(((3-phenylpropyl)phosphoryl)oxy)alkanoic acid moieties as P2-P3 replacements.	E. Merck Darmstadt
8474103	123	Potent and selective inhibitors of an aspartyl protease-like endothelin converting enzyme identified in rat lung.	Abbott Laboratories
1635057	48	Structure-activity relationships of a series of 2-amino-4-thiazole-containing renin inhibitors.	Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
1732531	88	Design and synthesis of potent, selective, and orally active fluorine-containing renin inhibitors.	Warner-Lambert
2066966	32	Renin inhibitors containing esters at the P2-position. Oral activity in a derivative of methyl aminomalonate.	Warner-Lambert
1956045	88	Substrate analogue renin inhibitors containing replacements of histidine in P2 or isosteres of the amide bond between P3 and P2 sites.	E. Merck Darmstadt
2120440	23	Orally potent human renin inhibitors derived from angiotensinogen transition state: design, synthesis, and mode of interaction.	Kissei Pharmaceutical
3783611	55	Inhibition of cathepsin D by substrate analogues containing statine and by analogues of pepstatin.	TBA
3531518	17	Design and synthesis of a potent and specific renin inhibitor with a prolonged duration of action in vivo.	TBA
3531517	17	Design and synthesis of potent and specific renin inhibitors containing difluorostatine, difluorostatone, and related analogues.	TBA
3906126	10	Difluorostatine- and difluorostatone-containing peptides as potent and specific renin inhibitors.	TBA
19615901	52	The P1N-isopropyl motif bearing hydroxyethylene dipeptide isostere analogues of aliskiren are in vitro potent inhibitors of the human aspartyl protease renin.	Nagasaki International University
	23	Novel low molecular renin inhibitors which show good oral blood pressure lowering effects in marmosets	TBA
3309313	48	Renin inhibitors. Dipeptide analogues of angiotensinogen incorporating transition-state, nonpeptidic replacements at the scissile bond.	Abbott Laboratories
3276890	28	Renin inhibitors. Design and synthesis of a new class of conformationally restricted analogues of angiotensinogen.	Abbott Laboratories
3137345	19	Synthesis and biological activity of some transition-state inhibitors of human renin.	Ciba-Geigy
3126296	43	Inhibition of porcine pepsin by two substrate analogues containing statine. The effect of histidine at the P2 subsite on the inhibition of aspartic proteinases.	University Of Wisconsin
1901910	87	New inhibitors of human renin that contain novel replacements at the P2 site.	Warner-Lambert
1552498	55	Renin inhibitors containing alpha-heteroatom amino acids as P2 residues.	Warner-Lambert
1404233	68	Renin inhibitors containing new P1-P1' dipeptide mimetics with heterocycles in P1'.	E. Merck Darmstadt